151 related articles for article (PubMed ID: 33503299)
21. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
[TBL] [Abstract][Full Text] [Related]
22. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.
Salaverria I; Philipp C; Oschlies I; Kohler CW; Kreuz M; Szczepanowski M; Burkhardt B; Trautmann H; Gesk S; Andrusiewicz M; Berger H; Fey M; Harder L; Hasenclever D; Hummel M; Loeffler M; Mahn F; Martin-Guerrero I; Pellissery S; Pott C; Pfreundschuh M; Reiter A; Richter J; Rosolowski M; Schwaenen C; Stein H; Trümper L; Wessendorf S; Spang R; Küppers R; Klapper W; Siebert R; ; ;
Blood; 2011 Jul; 118(1):139-47. PubMed ID: 21487109
[TBL] [Abstract][Full Text] [Related]
23. Early pattern of large B-cell lymphoma with IRF4 rearrangement.
Granai M; Lazzi S
Blood; 2020 Aug; 136(6):769. PubMed ID: 32761226
[No Abstract] [Full Text] [Related]
24. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
Feldman AL; Law M; Remstein ED; Macon WR; Erickson LA; Grogg KL; Kurtin PJ; Dogan A
Leukemia; 2009 Mar; 23(3):574-80. PubMed ID: 18987657
[TBL] [Abstract][Full Text] [Related]
25.
Büyüktaş D; Örnek S; Tokat F; Tecimer T; Ferhanoğlu B
Turk J Haematol; 2020 Nov; 37(4):292-294. PubMed ID: 32349466
[No Abstract] [Full Text] [Related]
26. Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China.
Zhang J; Sun J; Feng J; Luo Y; Ling Q; Wu S; Zeng X; Liang Z
Virchows Arch; 2018 Jul; 473(1):95-103. PubMed ID: 29802470
[TBL] [Abstract][Full Text] [Related]
27. Primary Low-Grade B-Cell Lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes.
Nasim MM; Chalif DJ; Demopoulos AM; Brody J; Lee-Huang R; Spitzer SG; Kolitz JE; Zhang X
Int J Surg Pathol; 2020 May; 28(3):330-335. PubMed ID: 31631721
[TBL] [Abstract][Full Text] [Related]
28. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
29. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
[TBL] [Abstract][Full Text] [Related]
30. Tonsillar follicular large B-cell lymphoma with
Yu YT; Sakata S; Takeuchi K; Medeiros LJ; Chang KC
J Clin Pathol; 2020 Feb; 73(2):120. PubMed ID: 31324665
[No Abstract] [Full Text] [Related]
31. Double-hit lymphoma demonstrating t(6;14;18)(p25;q32;q21), suggesting two independent dual-hit translocations, MYC/BCL-2 and IRF4/BCL-2.
Tabata R; Yasumizu R; Tabata C; Kojima M
J Clin Exp Hematop; 2013; 53(2):141-50. PubMed ID: 23995111
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics of high-grade B-cell lymphomas with rearrangement of MYC, bcl-6 and bcl-2].
Gong JY; Zhang YZ; Zhang JD; Zhang W; Li JQ; Ru K; Liu EB
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):14-18. PubMed ID: 29325245
[No Abstract] [Full Text] [Related]
33. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract][Full Text] [Related]
34. IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma.
Jiang XN; Yu F; Xue T; Xia QX; Bai QM; Yu BH; Shui RH; Zhou XY; Zhu XZ; Cao JN; Hong XN; Li XQ
Cancer Med; 2023 May; 12(9):10684-10693. PubMed ID: 37081786
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
39. Clinicopathological and prognostic significance of
Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
[No Abstract] [Full Text] [Related]
40. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
Wang W; Hu S; Lu X; Young KH; Medeiros LJ
Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
